Literature DB >> 22068865

Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited.

Johannes A N Dorresteijn1, Yolanda van der Graaf, Wilko Spiering, Diederick E Grobbee, Michiel L Bots, Frank L J Visseren.   

Abstract

Recent studies have challenged the notion that "lower is better" for blood pressure in relation to vascular events and mortality in patients with vascular disease, whereas practice guidelines currently recommend to lower blood pressure to <130/80 mm Hg. We reassessed this J-curved relationship between blood pressure and cardiovascular events and all-cause mortality in patients with various manifestations of vascular disease. For this purpose, 5788 patients with symptomatic vascular disease enrolled in the Secondary Manifestations of Arterial Disease Study were followed-up for the occurrence of new vascular events (ie, myocardial infarction, stroke, or vascular death) and all-cause mortality. During a median of 5.0 years (interquartile range: 2.6-8.1 years), 788 patients experienced a new vascular event, and 779 died. Overall, the covariate-adjusted relationship between mean baseline systolic, diastolic, or pulse pressure and the occurrence of vascular events followed a J-curve with increased event rates above and below the nadir blood pressure of 143/82 mm Hg. A similar nonlinear relationship was found for diastolic pressure and all-cause mortality. Elevated blood pressure was not associated with increased morbidity and mortality in patients with recently diagnosed coronary artery disease, ≥65 years, and having >60 mm Hg pulse pressure. Importantly, especially in these subgroups, low blood pressure could also be a symptom rather than a cause of disease. Blood pressure level below and above 143/82 mm Hg is, thus, an independent risk factor for recurrent events in patients with manifest vascular disease. Uncertainty of whether this association is causal provides a strong rationale for trials evaluating blood pressure treatment targets.

Entities:  

Mesh:

Year:  2011        PMID: 22068865     DOI: 10.1161/HYPERTENSIONAHA.111.179143

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  43 in total

1.  [Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?].

Authors:  C Chatzikyrkou; H Haller; J Menne
Journal:  Internist (Berl)       Date:  2012-07       Impact factor: 0.743

Review 2.  Hypertensive goals in patients with coronary artery disease.

Authors:  Ryan T Cunnane; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

Review 3.  J-shaped curve for cardiovascular mortality: systolic or diastolic blood pressure?

Authors:  Nicolás Roberto Robles; Francesco Fici; Guido Grassi
Journal:  J Nephrol       Date:  2018-09-17       Impact factor: 3.902

Review 4.  Blood Pressure in Older Adults: the Importance of Frailty.

Authors:  Michelle C Odden; Pamela R Beilby; Carmen A Peralta
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

Review 5.  Prevention of coronary artery disease: recent advances in the management of hypertension.

Authors:  Chiara Recarti; Thomas Unger
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

6.  [J curve: when lowering blood pressure becomes a hazard?].

Authors:  J Slany
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

7.  Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.

Authors:  Brian A Bergmark; Benjamin M Scirica; Ph Gabriel Steg; Christina L Fanola; Yared Gurmu; Ofri Mosenzon; Avivit Cahn; Itamar Raz; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2018-06-21       Impact factor: 29.983

8.  A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.

Authors:  John J Gildea; Dylan T Lahiff; Robert E Van Sciver; Ryan S Weiss; Neema Shah; Helen E McGrath; Cynthia D Schoeffel; Pedro A Jose; Robert M Carey; Robin A Felder
Journal:  Clin Chim Acta       Date:  2013-02-27       Impact factor: 3.786

Review 9.  Oscillating blood pressure therapeutic target in type 2 diabetes patients with hypertension.

Authors:  Aurel T Tankeu; Jean Jacques N Noubiap
Journal:  Ann Transl Med       Date:  2016-11

10.  Low blood pressure and antihypertensive treatment are independently associated with physical and mental health status in patients with arterial disease: the SMART study.

Authors:  M Muller; H M Jochemsen; F L J Visseren; A M Grool; L J Launer; Y van der Graaf; M I Geerlings
Journal:  J Intern Med       Date:  2013-04-11       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.